ALUR
Allurion Technologies, Inc.
NYSE: ALUR · HEALTHCARE · MEDICAL DEVICES
$0.74
-0.03% today
Updated 2026-04-29
Market cap
$8.96M
P/E ratio
—
P/S ratio
0.52x
EPS (TTM)
$-16.20
Dividend yield
—
52W range
$0 – $4
Volume
3.2M
Allurion Technologies, Inc. (ALUR) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-1.88%
Operating margin
-3.62%
ROE
0.00%
ROA
-0.72%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2020 | — | $-5169.00 | — | — | — |
| 2021 | $38.24M | $-12.39M | 76.33% | -32.69% | -32.39% |
| 2022 | $64.21M | $-37.74M | 79.00% | -49.85% | -58.78% |
| 2023 | $53.47M | $-80.61M | 77.61% | -147.90% | -150.76% |
| 2024 | $32.11M | $-26.15M | 66.97% | -156.33% | -81.43% |